drip bleeding with levonorgestrel-releasing intrauterine system
Conditions
Interventions
Experimental group:carbazochrome tablets
Control group:Estrogens
Sponsors
The Third Xiangya Hospital of Central South University
Eligibility
Sex/Gender
Female
Age
20 Years to 50 Years
Inclusion criteria
Inclusion criteria: 1. Aged 20 to 50 years; 2. Patients with levonorgestrel intrauterine sustained-release system placed in the gynecological outpatient department or inpatient department of our hospital due to gynecological diseases, and patients with intermenstrual bleeding at any time in the first month after surgery.
Exclusion criteria
Exclusion criteria: 1. Genital infection; 2. Atypical endometrial hyperplasia or endometrial cancer; 3. Severe liver and kidney dysfunction; 4. Those who have undergone endometrial resection; 5. Those with a history of epilepsy and mental illness; 6. Unwilling to follow up regularly.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Days of menstrual bleeding; | — |
Secondary
| Measure | Time frame |
|---|---|
| Endometrial thickness;Hemoglobin level; | — |
Countries
China
Contacts
Public ContactJiang Jianfa
The Third Xiangya Hospital of Central South University
Outcome results
None listed